- Acute Myeloid Leukaemia (AML): Preliminary Phase II clinical shows promising efficacy for bemcentinib in combo with low-intensity chemo in elderly AML patients unfit for intensive therapy - Non small cell lung cancer (NSCLC): Phase II clinical data continues to show promising clinical...
from PR Newswire: https://ift.tt/2TJOwSJ
No comments:
Post a Comment